Intuitive Surgical (NASDAQ:ISRG) EVP Sells $208,378.16 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $494.65, for a total value of $51,938.25.
• On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The stock was sold at an average price of $520.02, for a total value of $65,522.52.
• On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.
• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The shares were sold at an average price of $559.90, for a total value of $58,229.60.

Intuitive Surgical Stock Up 1.5%

Intuitive Surgical stock opened at $485.84 on Friday. The stock has a 50-day simple moving average of $541.62 and a 200 day simple moving average of $510.24. The stock has a market capitalization of $172.54 billion, a price-to-earnings ratio of 61.58, a P/E/G ratio of 3.71 and a beta of 1.65. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter last year, the company posted $2.21 EPS. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Riversedge Advisors LLC increased its position in shares of Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after buying an additional 17 shares in the last quarter. Fiduciary Financial Group LLC grew its stake in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after acquiring an additional 19 shares during the period. Prosperity Consulting Group LLC grew its stake in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after acquiring an additional 19 shares during the period. Rossmore Private Capital increased its holdings in shares of Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares in the last quarter. Finally, Activest Wealth Management raised its position in shares of Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Royal Bank Of Canada upped their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Rothschild & Co Redburn upped their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Piper Sandler reiterated an “overweight” rating and issued a $620.00 price target (up previously from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Raymond James Financial lifted their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Finally, Evercore cut their target price on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $617.23.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.